Literature DB >> 8427384

Leishmania colombiensis in Venezuela.

O Delgado1, M Castes, A C White, R D Kreutzer.   

Abstract

Flagellate parasites isolated in Venezuela from bone marrow aspirates of a human (MHOM/VE/70/Chuao) and a dog (MCAN/VE/72/Talisman2) were subsequently identified by isozyme analysis as Leishmania colombiensis. Data are presented describing genetic similarity among Panama, Colombia, and Venezuela populations of this species.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8427384     DOI： 10.4269/ajtmh.1993.48.145

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  4 in total

1.  A cross-sectional study on canine Leishmania (L.) infantum chagasi infection in Amazonian Brazil ratifies a higher prevalence of specific IgG-antibody response than delayed-type hypersensitivity in symptomatic and asymptomatic dogs.

Authors:  Fernando T Silveira; Liliane A Carneiro; Patrícia K S Ramos; Eugênia J Chagas; Luciana V R Lima; Marliane B Campos; Márcia D Laurenti; Claudia M C Gomes; Carlos E P Corbett
Journal:  Parasitol Res       Date:  2012-06-16       Impact factor: 2.289

2.  Comparison of Leishmania OligoC-TesT PCR with conventional and real-time PCR for Diagnosis of canine Leishmania infection.

Authors:  Connor Carson; Rupert J Quinnell; Jennifer Holden; Lourdes M Garcez; Stijn Deborggraeve; Orin Courtenay
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

3.  Canine leishmaniosis in South America.

Authors:  Filipe Dantas-Torres
Journal:  Parasit Vectors       Date:  2009-03-26       Impact factor: 3.876

4.  Genome Analysis of Endotrypanum and Porcisia spp., Closest Phylogenetic Relatives of Leishmania, Highlights the Role of Amastins in Shaping Pathogenicity.

Authors:  Amanda T S Albanaz; Evgeny S Gerasimov; Jeffrey J Shaw; Jovana Sádlová; Julius Lukeš; Petr Volf; Fred R Opperdoes; Alexei Y Kostygov; Anzhelika Butenko; Vyacheslav Yurchenko
Journal:  Genes (Basel)       Date:  2021-03-20       Impact factor: 4.096
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.